HomeProductsBuilding BlocksCarbocyclic ScaffoldsBenzene CompoundsLacosamide
Chemical structure of CAS 175481-36-4

Lacosamide

CAS No.175481-36-4
MDL No.MFCD08272557
MFC13H18N2O3
MW250.29
InChI KeyVPPJLAIAVCUEMN-GFCCVEGCSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Lacosamide is an N-acyl amino acid.

CAS No.175481-36-4
Product NameLacosamide

Biological Targets

SCN1A·SCN5A·SCN4A·SCN7A·SCN2A·

Associated Conditions

brain neoplasm·primary erythermalgia·Seizure·neuropathic pain·Anxiety·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Seeking a mechanism of action for the novel anticonvulsant lacosamide.

Neuropharmacology • Vol. 50, Issue 8 • 2006
PMID: 16620882DOI: 10.1016/j.neuropharm.2006.02.002

Diverse mechanisms of antiepileptic drugs in the development pipeline.

Epilepsy research • Vol. 69, Issue 3 • 2006
PMID: 16621450PMC: PMC1562526DOI: 10.1016/j.eplepsyres.2006.02.004

Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy.

European journal of pharmacology • Vol. 539, Issue 1-2 • 2006
PMID: 16682022DOI: 10.1016/j.ejphar.2006.04.009

Stereoselective effects of the novel anticonvulsant lacosamide against 4-AP induced epileptiform activity in rat visual cortex in vitro.

Neuropharmacology • Vol. 50, Issue 1 • 2006
PMID: 16225894DOI: 10.1016/j.neuropharm.2005.08.016

Documentation

Similar Products